Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is expected to report fourth-quarter 2025 results soon. The Zacks Consensus ...
In February, Democratic Socialists of America (DSA) reached the milestone of 100,000 members, with nearly 14,000 of them in New York City alone. The election of Zohran Mamdani, a longtime DSA activist ...
The race for LA mayor has two candidates from the Democratic Socialists of America (DSA), including City Council member Nithya Raman. It is worth a look at the DSA’s political platform. The first item ...
A specter is haunting New York politics – the specter of the Democratic Socialists of America. Over the past 10 years, the socialist organization has had its ups and downs, but recently it has been on ...
Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...
New York City’s chapter of the Democratic Socialists of America (DSA) is organizing a large-scale effort to mobilize thousands of activists to respond to anticipated federal immigration enforcement ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...
New York Mayor-elect Zohran Mamdani appointed more than 400 people to 17 transition committees on Monday, including two top leaders of the Democratic Socialists of America’s New York City branch.
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...